Dopaminergic restauratIon by intraVEntriculaire Administration

计划入组 12 人 · 首次发布于 2020 年 4 月 2 日

Evaluation of Long-term Safety in Parkinsonian Patients With Intracerebroventricular Administration of A-dopamine (Anaerobic Dopamine)

计划入组 1 人 · 首次发布于 2025 年 10 月 9 日

Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT Inhibitor

首次发布于 2016 年 10 月 11 日

ANPD-001

Dopamine(Neoatricon)

C₈H₁₁NO₂ · Rx

A9-DPC

A&A SMALL CHANGES HANDYPEOPLE

United States

Novozymes A/S

Denmark

Ambu A/S

Denmark

Novel Intracerebroventricular A-dopamine Treatment Shows Promise for Parkinson's Disease Complications

InBrain Pharma Secures €1.8 Million to Industrialize Anaerobic Dopamine Production for Advanced Parkinson's Disease

Intracerebroventricular Anaerobic Dopamine Reduces L-DOPA Complications in Parkinson's Disease